THE LONG-ACTING GLP-2 ANALOG APRAGLUTIDE PROVIDES CLINICAL BENEFIT FOR PATIENTS WITH SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE AND COLON IN CONTINUITY AT 52 WEEKS
Astrid Verbiest 1, 2
Mark Krogh Hvistendahl 3
Federico Bolognani 4
Carrie Li 4
Nader Youssef 4
Palle Bekker Jeppesen 4
Francisca Joly 5
Tim Vanuytsel 2, 1
1 University of Leuven, Leuven, Belgium
2 University Hospitals Leuven, Leuven, Belgium
3 Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
4 VectivBio AG, Basel, Switzerland
5 Hôpital Beaujon, Clichy, France
Topic
IBD, Small Intestine & Nutrition
Conference
UEG Week Copenhagen 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]